Decentrialz logo
  • HIPAA Compliant
  • ISO 27001 Certified
Find Trials
About UsContact
Become a Volunteer+1 877 705 1914

Status:

COMPLETED

THrombo-Embolic Event in Onco-hematology

Lead Sponsor:

Centre Antoine Lacassagne

Conditions:

Neoplasms

Thrombosis

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

The overall incidence of deep vein thrombosis (DVT) and pulmonary embolism (PE) is 1 per 200 cancer patients, about 5 times higher than in the general population. These events are of crucial importan...

Detailed Description

The overall incidence of deep vein thrombosis (DVT) and pulmonary embolism (PE) is 1 per 200 cancer patients, about 5 times higher than in the general population. These events are of crucial importan...

Eligibility Criteria

Inclusion

  • Patient followed for CAL cancer and admitted to the LTC in the Medicine Department.
  • Age\> to 18 years.
  • Patient having read the information note and signed the informed consent (including specific consent for genotyping of clotting factors).
  • Patient receiving social insurance.
  • Weight\> 50kg
  • Hemoglobin level\> 7.0 g / dl

Exclusion

  • Patient not benefiting as part of his treatment from hospitalization, but admitted on an ambulatory basis.
  • Patient whose age is less than 18 years.
  • Patient already included in the study.
  • Patient considered a vulnerable person; Vulnerable people are defined in Article L1121-5 to -8:
  • Pregnant women, parturients and breastfeeding mothers
  • Persons deprived of their liberty by a judicial or administrative decision, persons hospitalized without consent under Articles L. 3212-1 and L. 3213-1 who do not fall under the provisions of Article L. 1121-8
  • and persons admitted to a health or social institution for purposes other than research
  • adults who are legally protected or unable to express their consent

Key Trial Info

Start Date :

September 9 2019

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

September 9 2022

Estimated Enrollment :

700 Patients enrolled

Trial Details

Trial ID

NCT03826043

Start Date

September 9 2019

End Date

September 9 2022

Last Update

September 30 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Centre Antoine Lacassagne

Nice, France, 06189